Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:35 AM UTC
| NCT Number | NCT03972657 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 345 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT03972657 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 24 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03972657 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03972657 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.